GRANIONS Somdor+ Flash 20 tablets
In stock
Description
Why SOMDOR+ FLASH?
The Laboratoire des Granions®, committed to treating sleep-related problems, has developed a range of food supplements that meet the needs of all types of people who suffer from disturbed sleep.
SOMDOR+ FLASH has been specially formulated for all people prone to sleep problems related to a staggered rhythm. It is intended to facilitate sleep and reduce the effects of jet lag thanks to its dosage of 1.9 mg of melatonin. Its formula is completed by magnesium. Its sublingual form allows a release of 99.4% of the active ingredients in 2 minutes and a peak of melatonin in the blood in 10 minutes.
What are the benefits?
- Facilitates falling asleep (1)
- 99% of active ingredients released in 2 minutes
- Fast assimilation
Guaranteed gluten-free, vegetarian, sugar-free, no colouring or preservatives, with natural
natural red fruit flavours.
20 tablets - 20 day programme - Net weight 6 g
Food supplement with sweetener
(1) The beneficial effect is obtained by consuming 1 mg of melatonin before bedtime.
More Information
Ingredients
Sweetener: sorbitol, magnesium oxide, acidity regulator: sodium bicarbonate, acidifier: citric acid, natural flavour (dehydrated glucose syrup, gum arabic, monopropylene glycol), anti-caking agent: magnesium stearate, melatonin.
Composition :
Directions for use :
Take 1 tablet under the tongue in the evening before going to bed or if you wake up during the night, as a one-off or as part of a 20-day programme. Repeat if necessary.
Store in a cool, dry place, away from light.
Precautions for use :
It is advisable to consume this food supplement as part of a varied and balanced diet and a healthy lifestyle. Do not exceed the recommended dose. Keep out of reach of young children.
Excessive consumption may have laxative effects. Not recommended for pregnant and breast-feeding women, children and adolescents, people with epilepsy, asthma, mood, behaviour or personality disorders, people who have to carry out activities requiring sustained vigilance where drowsiness could pose a safety problem, people suffering from inflammatory or autoimmune diseases (melatonin).
This product has been developed and manufactured in accordance with the requirements of EN 17444 as of the production date of the batch. Compliance with the standard refers to the implementation of good development and manufacturing practices aimed at preventing the presence of prohibited substances but does not guarantee the absence of such substances. The standard does not constitute approval for use for those subject to anti-doping control.
